Clinical Trials Logo

Filter by:
NCT ID: NCT03609346 Completed - Clinical trials for STEMI - ST Elevation Myocardial Infarction

Asian Registry of the BioFreedom Stent for STEMI Patients

Start date: November 22, 2018
Phase:
Study type: Observational [Patient Registry]

The BioFreedom BA9 (Stainless Steel) Drug Coated Stent is an approved stent that is already commercially available in Europe and Asia. The purpose of this registry is to assess the safety and efficacy of the BioFreedom stent for treatment of a specific group of patients; patients with a myocardial infarction (STEMI). The objective is to capture patients' outcomes and antithrombotic strategies data using one or several BioFreedom Stents in the routine treatment of these STEMI patients.

NCT ID: NCT03608735 Completed - Clinical trials for Functional Gastrointestinal Disorders

Prevalence of Functional Gastrointestinal Disorders (FGIDs), Related Signs and Symptoms in Infants/Toddlers in Thailand

GI_Planet
Start date: November 7, 2018
Phase:
Study type: Observational

Prevalence and impact of Functional Gastrointestinal Disorders (FGIDs) and Related Signs and Symptoms in Infants and Toddlers in Thailand

NCT ID: NCT03608358 Terminated - Clinical trials for Type 2 Diabetes Mellitus

Safety and Efficacy of Dapagliflozin in Asian T2DM Subjects With Inadequate Glycemic Control on Metformin/Saxagliptin

Start date: February 27, 2019
Phase: Phase 3
Study type: Interventional

This is a 24-week, multicenter, randomized, double-blind, double-dummy, placebo-controlled, parallel group, phase 3 study designed to evaluate if the safety and efficacy of dapagliflozin 5 mg or 10 mg added to saxagliptin 5 mg plus metformin is superior to placebo added to saxagliptin 5 mg plus metformin in reducing hemoglobin A1c (HbA1c).

NCT ID: NCT03608033 Terminated - IgA Nephropathy Clinical Trials

Study of the Safety and Efficacy of OMS721 in Patients With Immunoglobulin A (IgA) Nephropathy

Start date: February 16, 2018
Phase: Phase 3
Study type: Interventional

The primary objective of this study is to evaluate the effect of OMS721 on 24-hour urine protein excretion (UPE) in IgA nephropathy (IgAN) patients with high baseline proteinuria (high-risk proteinuria group; 24-hour UPE ≥ 2 g/day) assessed at 36 weeks from baseline.

NCT ID: NCT03607071 Completed - Clinical trials for Myocardial Inflammation

Outcome of Steroid Therapy for Myocardial Inflammation in Scleroderma

Start date: May 15, 2018
Phase: Phase 2
Study type: Interventional

Primary myocardial involvement is common in scleroderma, effected to pericardium, vascular, conducting defect and especially myocardium. Cardiac MRI is widely used for assessment of cardiac involvement in scleroderma, both structural and functional pathology. Cardiac MRI has a diagnostic accuracy of 85% for the detection of myocardial inflammation. Nowadays, the treatment of myocardial inflammation in scleroderma is uncertain. The investigator's study aims to define the cardiac outcome after moderate dose steroid therapy in the patients who have myocardial inflammation detection by cardiac MRI.

NCT ID: NCT03606603 Completed - Malnutrition Clinical Trials

Nutrition Insights Day Asia

Start date: March 15, 2019
Phase:
Study type: Observational

This is an observational, cross-sectional study to be conducted on the Nutrition Insights Day (NID), with retrospective review of patient medical charts. No prospective follow-up period is considered. This study aims to obtain a contemporary overview of the nutritional status, the use of EN and/or PN and the provision of calories and proteins in patients after major elective gastrointestinal surgery with existing malnutrition or at risk of hospital malnutrition in selected Asian countries.

NCT ID: NCT03606408 Completed - Cushing's Syndrome Clinical Trials

Roll-over Study in Patients With Endogenous Cushing's Syndrome for LCI699

Start date: October 5, 2018
Phase: Phase 2
Study type: Interventional

The purpose of this study is the evaluation of long-term safety of osilodrostat in patients who have already received osilodrostat treatment in a previous Global Novartis-sponsored trial and who, based on investigators' judgement, will continue benefiting with its administration.

NCT ID: NCT03603834 Recruiting - Cholangiocarcinoma Clinical Trials

Neoadjuvant mFOLFOXIRI for Potentially Resectable Cholangiocarcinoma

Start date: September 19, 2018
Phase: Phase 2
Study type: Interventional

Previous reports suggest benefit of neoadjuvant chemotherapy/chemoradiation treatment for borderline resectable cholangiocarcinoma. This study is a single center prospective phase II study of neoadjuvant chemotherapy with mFOLFOXIRI in patients with borderline resectable cholangiocarcinoma.

NCT ID: NCT03603574 Completed - Clinical trials for Surgical Procedure, Unspecified

Epidural Waveform Analysis for Thoracic Epidural Blocks

Start date: July 30, 2018
Phase: N/A
Study type: Interventional

Epidural waveform analysis (EWA) provides a simple confirmatory adjunct for loss-of-resistance (LOR): when the needle/catheter tip is correctly positioned inside the epidural space, pressure measurement results in a pulsatile waveform. Epidural waveform analysis can be carried out through the tip of the needle or the catheter. In this randomized trial, the objective is to compare epidural waveform analysis through the needle (EWA-N) and through the catheter (EWA-C) for thoracic epidural blocks.

NCT ID: NCT03603197 Completed - Clinical trials for Metastatic Breast Cancer

BP-C1 in Short-term Treatment of Thai Patients With Metastatic Breast Cancer

Start date: June 5, 2014
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine whether BP-C1 is effective in the short-term treatment of metastatic breast cancer patients who have previously undergone at least three lines of chemotherapy.